Mesenchymal stem/stromal cell function in modulating cell death.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
13 02 2019
Historique:
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 6 5 2020
Statut: epublish

Résumé

Mesenchymal stem/stromal cells (MSCs) delivered as cell therapy to individuals with degenerative and/or inflammatory disorders can help improve organ features and resolve inflammation, as demonstrated in preclinical studies and to some extent in clinical studies. MSCs have trophic, homing/migration, and immunosuppression functions, with many benefits in therapeutics. MSC functions are thought to depend on the paracrine action of soluble factors and/or the expression of membrane-bound molecules, mostly belonging to the molecular class of adhesion molecules, chemokines, enzymes, growth factors, and interleukins. Cutting-edge studies underline bioactive exchanges, including that of ions, nucleic acids, proteins, and organelles transferred from MSCs to stressed cells, thereby improving the cells' survival and function. From this aspect, MSC death modulation function appears as a decisive biological function that could carry a significant part of the therapeutic effects of MSCs. Identifying the function and modes of actions of MSCs in modulating cell death may be exploited to enhance consistency and efficiency of cell therapy that is based on MSCs as medical treatment for degenerative and/or inflammatory diseases. Here, we review the essentials of MSC functions in modulating cell death in unfit cells, and its modes of actions based on current advances and outline the clinical implications.

Identifiants

pubmed: 30760307
doi: 10.1186/s13287-019-1158-4
pii: 10.1186/s13287-019-1158-4
pmc: PMC6374902
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

56

Références

Biomed Mater Eng. 2017;28(s1):S29-S45
pubmed: 28372276
Stem Cell Res Ther. 2016 Sep 09;7(1):131
pubmed: 27612948
Cell Death Differ. 2017 Jul;24(7):1224-1238
pubmed: 28524859
Stem Cells Transl Med. 2017 Mar;6(3):713-719
pubmed: 28297565
Sci Rep. 2013;3:1197
pubmed: 23378928
Circ Res. 2018 Aug 17;123(5):564-578
pubmed: 29921652
Nat Rev Drug Discov. 2013 May;12(5):347-57
pubmed: 23584393
Neuroscience. 2011 Oct 13;193:330-7
pubmed: 21763758
Nat Commun. 2015 Oct 07;6:8472
pubmed: 26442449
Stem Cell Reports. 2016 Jun 14;6(6):897-913
pubmed: 27304917
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
J Cell Mol Med. 2012 Dec;16(12):3085-95
pubmed: 22805279
Stem Cells Transl Med. 2016 Jun;5(6):845
pubmed: 27221332
Stem Cells. 2018 Jan;36(1):123-129
pubmed: 29067757
Stem Cells. 2018 Jul;36(7):1109-1121
pubmed: 29451335
Cytotherapy. 2015 Feb;17(2):125-7
pubmed: 25593076
Data Brief. 2015 Nov 01;5:864-70
pubmed: 26702413
Cytotherapy. 2018 Mar;20(3):273-278
pubmed: 29434007
Cell Death Dis. 2015 Sep 17;6:e1885
pubmed: 26379190
Lancet Neurol. 2012 Feb;11(2):150-6
pubmed: 22236384
J Neurochem. 2010 Mar;112(6):1527-38
pubmed: 20050969
Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L891-908
pubmed: 22307909
Cell Mol Neurobiol. 2012 May;32(4):567-76
pubmed: 22290155
Cell Transplant. 2016;25(5):829-48
pubmed: 26423725
Front Cardiovasc Med. 2017 May 22;4:32
pubmed: 28589127
J Cell Biochem. 2012 Sep;113(9):2806-12
pubmed: 22511358
Ann Rheum Dis. 2017 Jan;76(1):196-202
pubmed: 27269294
Am J Respir Cell Mol Biol. 2014 Sep;51(3):455-65
pubmed: 24738760
Neuroscience. 2010 Jun 2;167(4):1115-24
pubmed: 20153405
Stem Cells. 2007 Nov;25(11):2739-49
pubmed: 17656645
Bone Marrow Transplant. 2005 Jun;35(12):1201-9
pubmed: 15821761
Cell Death Dis. 2016 Jan 21;7:e2062
pubmed: 26794657
EMBO J. 2014 May 2;33(9):994-1010
pubmed: 24431222
BMC Cell Biol. 2010 Apr 20;11:29
pubmed: 20406471
Int J Mol Sci. 2016 Jul 19;17(7):
pubmed: 27447618
Cell Mol Neurobiol. 2017 Mar;37(2):303-313
pubmed: 27044018
Lancet. 2004 May 1;363(9419):1439-41
pubmed: 15121408
Cell Death Dis. 2018 Feb 13;9(2):218
pubmed: 29440630
J Cell Physiol. 2007 Nov;213(2):341-7
pubmed: 17620285
Nature. 2013 Mar 14;495(7440):227-30
pubmed: 23434756
Circ Res. 2016 Jan 8;118(1):95-107
pubmed: 26837742
J Orthop Res. 1991 Sep;9(5):641-50
pubmed: 1870029
Leukemia. 2016 Nov;30(11):2221-2231
pubmed: 27150009
Lancet. 2008 May 10;371(9624):1579-86
pubmed: 18468541
Nat Rev Mol Cell Biol. 2011 Feb;12(2):126-31
pubmed: 21253000
Cytotherapy. 2016 Feb;18(2):151-9
pubmed: 26724220
Mol Ther. 2017 Feb 1;25(2):465-479
pubmed: 28089078
Nat Immunol. 2011 May;12(5):391-8
pubmed: 21441933
J Cell Sci. 2017 Nov 1;130(21):3619-3630
pubmed: 29025971
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Cell Mol Life Sci. 2016 Jun;73(11-12):2405-10
pubmed: 27048813
N Engl J Med. 2009 Oct 15;361(16):1570-83
pubmed: 19828534
PLoS One. 2014 Feb 18;9(2):e88685
pubmed: 24558412
Cell Transplant. 2018 Jan;27(1):168-180
pubmed: 29562785
Cell Death Differ. 2014 Feb;21(2):216-25
pubmed: 24185619
Cell Biol Int. 2011 Dec;35(12):1247-51
pubmed: 21649586
Mol Med Rep. 2016 Feb;13(2):1517-24
pubmed: 26718099
Curr Opin Cell Biol. 2008 Aug;20(4):470-5
pubmed: 18456488
Nat Rev Immunol. 2014 Nov;14(11):759-67
pubmed: 25324125
Stem Cells. 2013 Nov;31(11):2296-303
pubmed: 23922260
Oncotarget. 2015 Mar 10;6(7):4953-67
pubmed: 25669974
Stem Cell Res Ther. 2016 Aug 31;7(1):125
pubmed: 27581859
JAMA Neurol. 2016 Mar;73(3):337-44
pubmed: 26751635
Haematologica. 2017 Sep;102(9):1594-1604
pubmed: 28596280
PLoS One. 2012;7(3):e33115
pubmed: 22431999
Cell Stem Cell. 2015 Jul 2;17(1):11-22
pubmed: 26140604
Stem Cells. 2018 Jan;36(1):79-90
pubmed: 29076623
Hum Gene Ther. 2010 Sep;21(9):1045-56
pubmed: 20565251
Microvasc Res. 2014 Mar;92:10-8
pubmed: 24486322
Stem Cells. 2008 Jan;26(1):151-62
pubmed: 17932421
Sci Rep. 2016 May 19;6:26162
pubmed: 27194621
Cell Stem Cell. 2008 Apr 10;2(4):313-9
pubmed: 18397751
Crit Rev Oncog. 2016;21(3-4):203-219
pubmed: 27915972
Arch Med Sci. 2017 Feb 1;13(1):236-245
pubmed: 28144277
J Physiol. 2004 Mar 16;555(Pt 3):617-26
pubmed: 14766937
Blood. 2011 Jul 14;118(2):380-9
pubmed: 21602525
Hepatol Res. 2018 Feb;48(3):E194-E202
pubmed: 28833919
Stem Cells. 2008 Sep;26(9):2287-99
pubmed: 18566331
Stem Cells Dev. 2013 Mar 15;22(6):845-54
pubmed: 23002959
Nat Med. 2013 Jul;19(7):812
pubmed: 23836216
Tissue Eng Part B Rev. 2014 Aug;20(4):233-42
pubmed: 24593258
Cytotherapy. 2013 Jan;15(1):2-8
pubmed: 23260081
Stem Cells. 2015 Jun;33(6):1878-91
pubmed: 25752682
Nat Med. 2012 Apr 15;18(5):759-65
pubmed: 22504485
J Am Soc Nephrol. 2009 May;20(5):1053-67
pubmed: 19389847
Cell Biol Int. 2010 Mar 12;34(4):415-23
pubmed: 20067445
Int J Cardiol. 2011 Nov 3;152(3):314-20
pubmed: 20674997
Stem Cell Res. 2013 Sep;11(2):793-805
pubmed: 23792435
Cell Stem Cell. 2018 Jun 01;22(6):824-833
pubmed: 29859173
J Hepatol. 2017 Jul;67(1):47-55
pubmed: 28284916
J Pathol. 2009 Jan;217(2):318-24
pubmed: 19023885
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Exp Hematol. 2006 Apr;34(4):536-48
pubmed: 16569600
J Cell Biochem. 2006 Aug 1;98(5):1076-84
pubmed: 16619257
Stem Cells. 2007 Jul;25(7):1753-60
pubmed: 17395776
FASEB J. 2018 May 29;:fj201701138RR
pubmed: 29812968
Stem Cell Res. 2015 Nov;15(3):655-664
pubmed: 26523674
Stem Cell Rev Rep. 2011 Sep;7(3):560-8
pubmed: 21437576
J Am Soc Nephrol. 2015 Oct;26(10):2349-60
pubmed: 25901032
Leuk Lymphoma. 2015 Jan;56(1):211-8
pubmed: 24724781
Stem Cells. 2015 Jul;33(7):2158-68
pubmed: 24964196
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1275-1286
pubmed: 28598224
J Proteomics. 2013 Jan 14;78:1-14
pubmed: 23153793
Cell Death Dis. 2017 Dec 11;8(12):3200
pubmed: 29233979

Auteurs

Abderrahim Naji (A)

Department of Environmental Medicine, Cooperative Medicine Unit, Research and Education Faculty, Medicine Science Cluster, Kochi Medical School (KMS), Kochi University, Kohasu, Oko-Cho, Nankoku City, Kochi Prefecture, 783-8505, Japan. najiab@kochi-u.ac.jp.

Benoit Favier (B)

CEA-Université Paris Sud INSERM U1184, IDMIT Department, IBFJ, DRF, Fontenay-aux-Roses, France.

Frédéric Deschaseaux (F)

STROMALab, UMR 5273 CNRS, INSERM U1031, Etablissement Français du Sang (EFS) Occitanie, Université de Toulouse, Toulouse, France.

Nathalie Rouas-Freiss (N)

CEA, DRF-Institut Francois Jacob, Division de recherche en hématologie et immunologie (SRHI), Hôpital Saint-Louis, Paris, France.

Masamitsu Eitoku (M)

Department of Environmental Medicine, Cooperative Medicine Unit, Research and Education Faculty, Medicine Science Cluster, Kochi Medical School (KMS), Kochi University, Kohasu, Oko-Cho, Nankoku City, Kochi Prefecture, 783-8505, Japan.

Narufumi Suganuma (N)

Department of Environmental Medicine, Cooperative Medicine Unit, Research and Education Faculty, Medicine Science Cluster, Kochi Medical School (KMS), Kochi University, Kohasu, Oko-Cho, Nankoku City, Kochi Prefecture, 783-8505, Japan. nsuganuma@kochi-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH